r Treatment processes in Kosovo public hospitals are carried out through the "Essential Medicine List" and "Essential Material List" determined by the state. According to official data, Prizren Hospital has the highest rate of essential medicine supply with 89.10%, while this rate is in the range of 72% to 76% in important centers such as Gilan and Gjakova. Coverage rates for basic medical materials are on average between 67% and 79%. This statistical table, which cannot reach one hundred percent, indicates that even public inpatients have to obtain some of their medicines and medical consumables such as basic dressings and syringes directly from private pharmacies. Market Opportunity for Private Pharmacies and B2B Supply Product groups that are not included in the Essential Medicines List or are restricted, such as cancer treatment (oncology), advanced cardiovascular drugs and new generation antibiotics, are the main profitability items of private pharmacies and pharmaceutical distributors. Modern pharmacies and medical device supply companies located in commercial locations (real estate) opposite the hospital have the potential to create a stable cash flow.
When the Kosovo Statistics Agency's Health_and_Welfare__Clinical pharmacy_ 2016.csv file is examined, the following data regarding the usage percentages of the "Essential Drug List" and "Essential Material List" of the Clinical Pharmacy units of regional general hospitals stand out: Highest Supply Rates (Prizren and Ferizaj): Among the hospitals, the center with the highest rate of meeting the basic drug needs is Prizren Hospital with 89.10%. The coverage rate of the basic medical material list is 79.40% here.
Key Indicators
ASK Data — Interactive Charts
Investor Insight
This situation points to a stable market potential for pharmaceutical import companies, medical consumable (B2B) suppliers, and investors seeking to establish modern pharmacy chains. Data-Driven Analysis: In developing healthcare economies, one of the areas investors focus on most is the pharmacology and medical product supply chain. Foreign investors' medical products must be registered with the Kosovo Medical Products and Devices Agency (AKPPM).
- ✦There is a profitable basis for B2B (wholesale to public and private hospitals) medical supply suppliers and B2C retail pharmacy chains.
- ✦Market Opportunity for Private Pharmacies and B2B Supply Product groups that are not included in the Essential Medicines List or are restricted, such as cancer treatment (oncology), advanced cardiovascular drugs and new generation antibiotics, are the main profitability items of private pharmacies and pharmaceutical distributors.
- ✦Modern pharmacies and medical device supply companies located in commercial locations (real estate) opposite the hospital have the potential to create a stable cash flow.
- ▲Pharmacy openings require a licensed local (or foreign equivalent approved) pharmacist registered with the Kosovo Chamber of Pharmacists.
- ▲Sectoral legislation, licensing and legal processes should also be examined.
More Analyses in This Category
Kosovo Cardiology and Cardiovascular Surgery Market: Investment Data
Read more →Kosovo Mental Health Services and Psychology Center Investment
Read more →Kosovo Medical Pharmaceuticals and Pharmacy Market: Investment Data Analysis
Read more →Elderly People Deprived of Family Care and Nursing Home Investment Opportunities in Kosovo
Read more →This content has been prepared by Kosova Investment Joint Venture with legal and investment perspective contributed by Av. Mehmet Vehbi Filiz. The information is for general guidance only and does not constitute legal, tax, financial or immigration advice.
Av. Mehmet Vehbi Filiz
Prepared under the editorial framework of Kosova Investment / KS Law Consultancy L.L.C.
About Kosova Investment⚠️ Legal Disclaimer — Not Investment Advice
This content is for informational purposes only and does not constitute investment advice, financial guidance, or a business formation offer. Data presented is compiled from the Kosovo Agency of Statistics (ASK) and related official sources; its accuracy is not guaranteed. You are strongly advised to consult an independent financial advisor, legal counsel, or relevant professional before making any investment decisions. Kosova Investment Joint Venture / KS Law Consultancy L.L.C. shall not be held liable for any direct or indirect damages arising from reliance on this content.
This content was prepared by Av. Mehmet Vehbi Filiz under Kosova Investment / KS Law Consultancy L.L.C. Editorial analyses, explanations, chart interpretations, Q&As, and investor assessments may not be copied, reproduced, or used commercially on other platforms without written permission. Official data sources must be cited separately.